Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

FOPO nets $12.7mm for InspireMD

Executive Summary

InspireMD Inc. (embolic protection systems) netted $12.7mm through the follow-on public sale of 34.5mm common shares at $0.40 each. The company also issued five-year warrants to buy another 34.5mm shares exercisable at $0.55 per share. The funds will help support the launch of its CGuard EPS and commercialization of MGuard Prime.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies

UsernamePublicRestriction

Register